HBIO icon

Harvard Bioscience
HBIO

Overview Fund Activity

70 hedge funds and large institutions have $60.6M invested in Harvard Bioscience in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 15 closing their positions.

Holders
70
Holders Change
-12
Holders Change %
-14.63%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
3
Increased
28
Reduced
22
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
KCM
1
Kennedy Capital Management
Missouri
$1.34M
2
GPC
2
Glacier Peak Capital
Washington
$1.78M
3
RA
3
Royce & Associates
New York
$4.52M
4
HA
4
Heartland Advisors
Wisconsin
$6.26M
5
PCMI
5
Paradigm Capital Management Inc
New York
$1.58M

Top Sellers

1
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$2.85M
2
CCM
2
Cadence Capital Management
Massachusetts
$0
3
TA
3
Teton Advisors
New York
$0
4
Millennium Management
4
Millennium Management
New York
$125K
5
PP
5
Paloma Partners
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CS
76
Credit Suisse
Switzerland
– – -60,635 Closed
SB
77
Suntrust Banks
Georgia
– – -59,846 Closed
Deutsche Bank
78
Deutsche Bank
Germany
$0 8 -37,118 -100%
LP
79
LMR Partners
United Kingdom
– – -27,199 Closed
AGM
80
Alpine Global Management
New York
– – -24,782 Closed
Jane Street
81
Jane Street
New York
– – -20,011 Closed
OAM
82
Oxford Asset Management
United Kingdom
– – -12,392 Closed
Squarepoint
83
Squarepoint
New York
– – -11,200 Closed
JC
84
JBF Capital
Colorado
– – -6,200 Closed
Barclays
85
Barclays
United Kingdom
– – -2,848 Closed
1 2 3
4